top of page


šš³ ššš šš¶š²šæš. š° š¾šš²ššš¶š¼š»š. š¢š»š¹š šÆ š½š®šš.
I mapped every subscription tier from OpenAI, Anthropic, Google, and Mistral against four questions a pharma board needs answered before any AI procurement decision. The result is sobering. š§šµš² š° š¾šš²ššš¶š¼š»š: š. Does the provider train on our inputs by default? š®. Can we lawfully process EU personal data on this tier (GDPR)? šÆ. Can we lawfully process US patient data on this tier (HIPAA)? š°. Is DPA + BAA + Zero Data Retention available on the same tier? š§šµš²

Christian Schulze
May 212 min read


š¬š¼ššæ ššš šæšš»š š¼š» š® š¦š¼šš²šæš²š¶š“š» šš¹š¼šš±. š§šµš² ššØ ššµš¶š»šøš š¶š š¶š š»š¼š šš¼šš²šæš²š¶š“š».
A pharma client recently told me: "We moved to AWS European Sovereign Cloud. We are GDPR-safe now." I asked one question: "Who owns the parent company?" Silence. Here is what most people miss: no US hyperscaler sovereign cloud fully eliminates CLOUD Act exposure as of May 2026. Not AWS ESC. Not Microsoft Bleu or Delos. Not Google T-Systems. The European Commission's Cloud Sovereignty Framework, the EDPB, and the French Senate (where US providers conceded they cannot guarantee

Christian Schulze
May 182 min read
bottom of page
